ClariVest Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-24,422
| Closed | -$1.29M | – | 854 |
|
|
2020
Q3 | $1.29M | Sell |
24,422
-1,038
| -4% | -$64.1K | 0.04% | 278 |
|
|
2020
Q2 | $1.56M | Sell |
25,460
-1,013
| -4% | -$58.6K | 0.04% | 265 |
|
|
2020
Q1 | $1.5M | Sell |
26,473
-460
| -2% | -$26.2K | 0.04% | 236 |
|
|
2019
Q4 | $1.53M | Sell |
26,933
-11,924
| -31% | -$632K | 0.04% | 283 |
|
|
2019
Q3 | $2.08M | Sell |
38,857
-300
| -0.8% | -$17.5K | 0.05% | 252 |
|
|
2019
Q2 | $2.34M | Sell |
39,157
-493
| -1% | -$31K | 0.05% | 234 |
|
|
2019
Q1 | $2.47M | Sell |
39,650
-1,615
| -4% | -$107K | 0.05% | 294 |
|
|
2018
Q4 | $2.5M | Buy |
41,265
+11,433
| +38% | +$683K | 0.05% | 264 |
|
|
2018
Q3 | $1.75M | Sell |
29,832
-1,214
| -4% | -$61.9K | 0.03% | 343 |
|
|
2018
Q2 | $1.39M | Sell |
31,046
-607
| -2% | -$26.1K | 0.02% | 399 |
|
|
2018
Q1 | $1.4M | Buy |
31,653
+300
| +1% | +$12.6K | 0.02% | 381 |
|
|
2017
Q4 | $1.36M | Buy |
31,353
+6,580
| +27% | +$296K | 0.02% | 387 |
|
|
2017
Q3 | $1.15M | Buy |
24,773
+100
| +0.4% | +$4.79K | 0.03% | 332 |
|
|
2017
Q2 | $1.22M | Sell |
24,673
-9
| -0% | -$471 | 0.03% | 323 |
|
|
2017
Q1 | $1.35M | Buy |
24,682
+14,175
| +135% | +$750K | 0.03% | 315 |
|
|
2016
Q4 | $585K | Buy |
10,507
+2,100
| +25% | +$101K | 0.02% | 389 |
|
|
2016
Q3 | $384K | Buy |
8,407
+100
| +1% | +$4.02K | 0.01% | 416 |
|
|
2016
Q2 | $332K | Buy |
8,307
+400
| +5% | +$14.6K | 0.01% | 410 |
|
|
2016
Q1 | $275K | Buy |
7,907
+100
| +1% | +$3.67K | 0.01% | 424 |
|
|
2015
Q4 | $336K | Buy |
7,807
+1,500
| +24% | +$75.2K | 0.01% | 393 |
|
|
2015
Q3 | $274K | Hold |
6,307
| – | – | 0.01% | 381 |
|
|
2015
Q2 | $325K | Buy |
6,307
+100
| +2% | +$4.26K | 0.01% | 364 |
|
|
2015
Q1 | $242K | Hold |
6,207
| – | – | 0.01% | 386 |
|
|
2014
Q4 | $239K | Buy |
6,207
+207
| +3% | +$7.9K | 0.01% | 324 |
|
|
2014
Q3 | $212K | Buy |
+6,000
| New | +$176K | 0.01% | 358 |
|
Other funds holding BSTC
ClariVest Asset Management's BSTC Position: Q4 2020 in Review
ClariVest Asset Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 24,422 shares — an estimated $1.29M sold.
ClariVest Asset Management first reported a position in BSTC in Q3 2014 and held it in 25 quarters. The position peaked at $2.5M in Q4 2018. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- ClariVest Asset Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- ClariVest Asset Management sold 24,422 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1.29M.
- ClariVest Asset Management first reported a position in BioSpecifics Technologies Corp. in Q3 2014 and held it in 25 quarters.
- ClariVest Asset Management's BioSpecifics Technologies Corp. position peaked at $2.5M in Q4 2018.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on ClariVest Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.